By increasing histone acetylation, martinostat can restore pro-apoptotic factors (e.g., BAD and BIK) and tumor suppressors (e.g., PTEN), suppress pro-survival genes, and restore critical pathways. This evidence concerns the gene BAD and neoplasm.